NPI: 1457673345 · FORREST CITY, AR 72335 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/19/2010
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/19/2010 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 11,356 | $115K |
| 2019 | 11,811 | $104K |
| 2020 | 10,553 | $106K |
| 2021 | 11,068 | $105K |
| 2022 | 8,762 | $132K |
| 2023 | 2,989 | $91K |
| 2024 | 2,420 | $83K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 21,886 | 1,702 | $353K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 18,320 | 1,082 | $120K |
| 83970 | 623 | 519 | $88K | |
| 82728 | 387 | 318 | $41K | |
| 82108 | 94 | 82 | $27K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 10,648 | 902 | $27K |
| A4657 | Syringe, with or without needle, each | 1,289 | 1,019 | $18K |
| 83540 | 373 | 293 | $14K | |
| 83550 | 319 | 254 | $13K | |
| 85041 | 893 | 771 | $9K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 53 | 45 | $8K |
| 85048 | 884 | 765 | $7K | |
| 82746 | 111 | 99 | $6K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 141 | 74 | $4K |
| J1756 | Injection, iron sucrose, 1 mg | 2,653 | 631 | $623.88 |
| 90674 | 29 | 29 | $531.45 | |
| G0008 | Administration of influenza virus vaccine | 50 | 46 | $306.30 |
| 82607 | 14 | 13 | $67.27 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 99 | 59 | $0.00 |
| 85045 | 93 | 88 | $0.00 |